Melanocortin receptor agonists
Abstract:
The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
Public/Granted literature
Information query
Patent Agency Ranking
0/0